ASX - By Stock
|
TLX Biotech |
Re:
Telix at the European Association of Urology Congress 2022, Focus on PSMA-PET Imaging
|
|
89zirconium
|
4 |
2.1K |
0 |
02/08/22 |
02/08/22 |
ASX - By Stock
|
4
|
2.1K
|
0
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Telix at the European Association of Urology Congress 2022, Focus on PSMA-PET Imaging
|
|
89zirconium
|
4 |
2.1K |
0 |
02/08/22 |
02/08/22 |
ASX - By Stock
|
4
|
2.1K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
The China conection
|
|
89zirconium
|
15 |
5.7K |
0 |
02/08/22 |
02/08/22 |
ASX - By Stock
|
15
|
5.7K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
The China conection
|
|
89zirconium
|
15 |
5.7K |
0 |
02/08/22 |
02/08/22 |
ASX - By Stock
|
15
|
5.7K
|
0
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Carbonic Anhydrase IX-Targeted α-Radionuclide Therapy w/ 225Ac Inhibits Tumor Growth in Renal Cell Carc. Model
|
|
89zirconium
|
4 |
1.8K |
0 |
02/08/22 |
02/08/22 |
ASX - By Stock
|
4
|
1.8K
|
0
|
|
ASX - By Stock
|
TLX Biotech |
Moderated
|
|
89zirconium
|
6 |
3.9K |
0 |
02/08/22 |
02/08/22 |
ASX - By Stock
|
6
|
3.9K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Becoming a substantial holder
|
|
89zirconium
|
14 |
4.4K |
0 |
01/08/22 |
01/08/22 |
ASX - By Stock
|
14
|
4.4K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Becoming a substantial holder
|
|
89zirconium
|
14 |
4.4K |
0 |
01/08/22 |
01/08/22 |
ASX - By Stock
|
14
|
4.4K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Becoming a substantial holder
|
|
89zirconium
|
14 |
4.4K |
0 |
01/08/22 |
01/08/22 |
ASX - By Stock
|
14
|
4.4K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Becoming a substantial holder
|
|
89zirconium
|
14 |
4.4K |
0 |
01/08/22 |
01/08/22 |
ASX - By Stock
|
14
|
4.4K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Becoming a substantial holder
|
|
89zirconium
|
14 |
4.4K |
0 |
01/08/22 |
01/08/22 |
ASX - By Stock
|
14
|
4.4K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Becoming a substantial holder
|
|
89zirconium
|
14 |
4.4K |
0 |
01/08/22 |
01/08/22 |
ASX - By Stock
|
14
|
4.4K
|
0
|
|
Charts
|
TLX |
Re:
2022 CHART THREAD
|
|
89zirconium
|
338 |
112K |
0 |
01/08/22 |
01/08/22 |
Charts
|
338
|
112K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Becoming a substantial holder
|
|
89zirconium
|
14 |
4.4K |
0 |
01/08/22 |
01/08/22 |
ASX - By Stock
|
14
|
4.4K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Becoming a substantial holder
|
|
89zirconium
|
14 |
4.4K |
0 |
01/08/22 |
01/08/22 |
ASX - By Stock
|
14
|
4.4K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Zircon Kidney Cancer Imaging Study completes Enrollment
|
|
89zirconium
|
34 |
8.9K |
0 |
30/07/22 |
30/07/22 |
ASX - By Stock
|
34
|
8.9K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
Shorters discover Telix
|
|
89zirconium
|
234 |
86K |
0 |
30/07/22 |
30/07/22 |
ASX - By Stock
|
234
|
86K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Trading Halt
|
|
89zirconium
|
36 |
16K |
0 |
29/07/22 |
29/07/22 |
ASX - By Stock
|
36
|
16K
|
0
|
|
Charts
|
TLX |
Re:
2022 CHART THREAD
|
|
89zirconium
|
338 |
112K |
1 |
29/07/22 |
29/07/22 |
Charts
|
338
|
112K
|
1
|
|
Charts
|
TLX |
Re:
2022 CHART THREAD
|
|
89zirconium
|
338 |
112K |
2 |
29/07/22 |
29/07/22 |
Charts
|
338
|
112K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Zircon Kidney Cancer Imaging Study completes Enrollment
|
|
89zirconium
|
34 |
8.9K |
2 |
29/07/22 |
29/07/22 |
ASX - By Stock
|
34
|
8.9K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Trading Halt
|
|
89zirconium
|
36 |
16K |
0 |
29/07/22 |
29/07/22 |
ASX - By Stock
|
36
|
16K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Trading Halt
|
|
89zirconium
|
36 |
16K |
0 |
29/07/22 |
29/07/22 |
ASX - By Stock
|
36
|
16K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
News: TLX Telix Pharmaceuticals Says Kevin Richardson Appointed As CEO, Telix Americas
|
|
89zirconium
|
10 |
3.2K |
0 |
29/07/22 |
29/07/22 |
ASX - By Stock
|
10
|
3.2K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
News: TLX Telix Pharmaceuticals Says Kevin Richardson Appointed As CEO, Telix Americas
|
|
89zirconium
|
10 |
3.2K |
1 |
29/07/22 |
29/07/22 |
ASX - By Stock
|
10
|
3.2K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
News: TLX Telix Pharmaceuticals Says Kevin Richardson Appointed As CEO, Telix Americas
|
|
89zirconium
|
10 |
3.2K |
0 |
29/07/22 |
29/07/22 |
ASX - By Stock
|
10
|
3.2K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
News: TLX Telix Pharmaceuticals Says Kevin Richardson Appointed As CEO, Telix Americas
|
|
89zirconium
|
10 |
3.2K |
0 |
29/07/22 |
29/07/22 |
ASX - By Stock
|
10
|
3.2K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
News: TLX Telix Pharmaceuticals Says Kevin Richardson Appointed As CEO, Telix Americas
|
|
89zirconium
|
10 |
3.2K |
2 |
29/07/22 |
29/07/22 |
ASX - By Stock
|
10
|
3.2K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
News: TLX Telix Pharmaceuticals Says Kevin Richardson Appointed As CEO, Telix Americas
|
|
89zirconium
|
10 |
3.2K |
0 |
29/07/22 |
29/07/22 |
ASX - By Stock
|
10
|
3.2K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
Lantheus reporting tonight
|
|
89zirconium
|
5 |
1.5K |
0 |
28/07/22 |
28/07/22 |
ASX - By Stock
|
5
|
1.5K
|
0
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Targeted Radiopharmaceutical Summit US
|
|
89zirconium
|
7 |
4.7K |
0 |
27/07/22 |
27/07/22 |
ASX - By Stock
|
7
|
4.7K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
Lantheus reporting tonight
|
|
89zirconium
|
5 |
1.5K |
0 |
27/07/22 |
27/07/22 |
ASX - By Stock
|
5
|
1.5K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
Lantheus reporting tonight
|
|
89zirconium
|
5 |
1.5K |
0 |
27/07/22 |
27/07/22 |
ASX - By Stock
|
5
|
1.5K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
Lantheus reporting tonight
|
|
89zirconium
|
5 |
1.5K |
0 |
27/07/22 |
27/07/22 |
ASX - By Stock
|
5
|
1.5K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
Lantheus reporting tonight
|
|
89zirconium
|
5 |
1.5K |
0 |
27/07/22 |
27/07/22 |
ASX - By Stock
|
5
|
1.5K
|
0
|
|
ASX - By Stock
|
TLX |
Lantheus reporting tonight
|
|
89zirconium
|
5 |
1.5K |
0 |
27/07/22 |
27/07/22 |
ASX - By Stock
|
5
|
1.5K
|
0
|
|
Charts
|
TLX |
Re:
2022 CHART THREAD
|
|
89zirconium
|
338 |
112K |
0 |
27/07/22 |
27/07/22 |
Charts
|
338
|
112K
|
0
|
|
Charts
|
TLX |
Re:
2022 CHART THREAD
|
|
89zirconium
|
338 |
112K |
1 |
26/07/22 |
26/07/22 |
Charts
|
338
|
112K
|
1
|
|
Charts
|
TLX |
Re:
2022 CHART THREAD
|
|
89zirconium
|
338 |
112K |
0 |
26/07/22 |
26/07/22 |
Charts
|
338
|
112K
|
0
|
|
Charts
|
TLX |
Re:
2022 CHART THREAD
|
|
89zirconium
|
338 |
112K |
0 |
26/07/22 |
26/07/22 |
Charts
|
338
|
112K
|
0
|
|
Charts
|
TLX |
Re:
2022 CHART THREAD
|
|
89zirconium
|
338 |
112K |
0 |
26/07/22 |
26/07/22 |
Charts
|
338
|
112K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
Forecasting Quarterly Sales Figures
|
|
89zirconium
|
64 |
16K |
0 |
25/07/22 |
25/07/22 |
ASX - By Stock
|
64
|
16K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Zircon Kidney Cancer Imaging Study completes Enrollment
|
|
89zirconium
|
34 |
8.9K |
1 |
25/07/22 |
25/07/22 |
ASX - By Stock
|
34
|
8.9K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
89zirconium vs 89zirconiium
|
|
89zirconium
|
17 |
6.3K |
0 |
24/07/22 |
24/07/22 |
ASX - By Stock
|
17
|
6.3K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
89zirconium vs 89zirconiium
|
|
89zirconium
|
17 |
6.3K |
0 |
23/07/22 |
23/07/22 |
ASX - By Stock
|
17
|
6.3K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
89zirconium vs 89zirconiium
|
|
89zirconium
|
17 |
6.3K |
0 |
23/07/22 |
23/07/22 |
ASX - By Stock
|
17
|
6.3K
|
0
|
|
Charts
|
TLX |
Re:
2022 CHART THREAD
|
|
89zirconium
|
338 |
112K |
1 |
23/07/22 |
23/07/22 |
Charts
|
338
|
112K
|
1
|
|
Charts
|
TLX |
Re:
2022 CHART THREAD
|
|
89zirconium
|
338 |
112K |
1 |
23/07/22 |
23/07/22 |
Charts
|
338
|
112K
|
1
|
|
Charts
|
TLX |
Re:
2022 CHART THREAD
|
|
89zirconium
|
338 |
112K |
0 |
23/07/22 |
23/07/22 |
Charts
|
338
|
112K
|
0
|
|
Charts
|
TLX |
Re:
2022 CHART THREAD
|
|
89zirconium
|
338 |
112K |
1 |
23/07/22 |
23/07/22 |
Charts
|
338
|
112K
|
1
|
|